Letter

New antipsychotic agents are much awaited

BMJ 2006; 332 doi: 10.1136/bmj.332.7556.1511 (Published 22 June 2006)
Cite this as: BMJ 2006;332:1511.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Arnob Chakraborti, senior house officer (ac97dmc@googlemail.com)
  1. Dorothy Pattison Hospital, Walsall Primary Care Trust, Walsall WS2 9XH

    EDITOR—I agree with Ganguli and Strassnig that truly novel antipsychotic agents are needed.1 They talk about older antipsychotics not becoming obsolete in clinical practice, while the amount of research that is conducted solely into their efficacy is slim. We remain in the dark when it comes to comparing typical antipsychotics, individualising them to the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular